Viewing StudyNCT00251225



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00251225
Status: COMPLETED
Last Update Posted: 2017-08-09
First Post: 2005-11-08

Brief Title: A Study of Imatinib and Docetaxel in Prostate Cancer
Sponsor: Leonard Appleman
Organization: University of Pittsburgh

Organization Data

Organization: University of Pittsburgh
Class: OTHER
Study ID: 05-019
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Leonard Appleman
Lead Sponsor Class: OTHER
Responsible Party: Leonard Appleman
Responsible Party Title: MD
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation: University of Pittsburgh
Old Name: None
Old Organization: None

Collaborators

Name Class
Novartis Pharmaceuticals INDUSTRY